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Abstract
Objective: To assess the effectiveness of platelet rich plasma (PRP) injections in the treatment of chronic
plantar fasciitis compared to traditional corticosteroid injections. Design: Systematic literature review.
Methods: A literature search was performed in Pubmed using the search terms “plantar fasciitis” and
“platelet rich plasma”. Inclusion criteria included publication within 10 years, randomized control trial,
human study, and containing the American Orthopedic Foot and Ankle Society (AOFAS) hindfoot
scoring system. Results: Our literature search resulted in the review of three randomized- control trials.
Mahindra et al. showed that PRP was superior to corticosteroid injections in the treatment of chronic
plantar fasciitis at 3 months. Acosto-Olivo et al. found both treatments were equally effective at reducing
symptoms of plantar fasciitis over a 16- week period. Similar to Mahindra et al., Monto found that PRP
was a more effective treatment for maintaining remission of chronic plantar fasciitis over a 24- month
period. Conclusion: PRP injections are shown to be as effective or more effective than corticosteroid
injections in the treatment of chronic plantar fasciitis that has failed conservative treatment.
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Introduction
Plantar fasciitis accounts for approximately one million healthcare visits per year and 11-15% of
adult foot symptoms requiring medical care.1,2 The deep plantar fascia is a thick tissue with longitudinal
fibers that are intimately attached to the skin.3 The fascia provides arch support during jumping, walking,
and standing.1 The causes of plantar fasciitis are multifactorial. Identifying an individual's risk factors are
essential in order to create a successful treatment plan. Risk factors include obesity, flat fleet, overuse,
trauma, and prolonged jumping or standing.1, 4 Plantar fasciitis is typically diagnosed in those between the
ages of 40 - 60 years old, but may be seen at younger ages especially in athletes.1,4
Plantar fasciitis typically presents as heel pain that is worse in the morning or after periods of
inactivity. The pain initially decreases throughout the day, but then worsens with extended periods of
walking or standing.4 Patients may complain of localized tenderness over the medial aspect of the heel.4
In addition, patients may complain of pain with dorsiflexion and standing on their toes.3 A diagnosis of
plantar fasciitis can be made clinically.2,3
Initial treatments for plantar fasciitis are conservative and include a combination of non-steroidal
anti-inflammatory drugs (NSAIDS), orthopedic shoes and exercise therapy. However, 10% of patients do
not improve with conservative measures and progress to have debilitating chronic plantar fasciitis.7
Treatment of chronic plantar fasciitis includes a trial of corticosteroids injections along points of
tenderness in the plantar fascia.1 In a randomized control trail of 65 patients, pain was significantly
reduced in those who received an injection of methylprednisolone compared to placebo injection.5
Treatment with corticosteroid injections has significant drawbacks though, as repeated injections can
cause heel pad atrophy and plantar fascia rupture.6
Local PRP injections are an emerging treatment modality in the management of chronic tendon
and ligament pathologies, including plantar fasciitis.7,8,9 The theory behind PRP treatment is that an
injection of large doses of growth factors, cytokines and cellular contents into soft tissue will promote
cellular proliferation and possibly regeneration.4 An injection of PRP directly at the site of tenderness
within the plantar fascia allows these contents to reach an area that is otherwise relatively inaccessible due
to its hypovascularity.7 The aim of this review is to determine whether PRP injections are more effective
than corticosteroid injections in the treatment of chronic plantar fasciitis.
Methods
An initial literature search in Pubmed was performed in September of 2018 (Figure 1). The search
terms “plantar fasciitis” and “platelet rich plasma” produced 63 results. Duplicate articles were removed
yielding 63 results. Inclusion criteria included articles being published within the past 10 years,
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randomized control trials, and human studies. Once inclusion criteria was assessed, 8 articles met the
criteria for our research. Additional articles were excluded due to irrelevance and not using the AOFAS
hindfoot scoring system to assess subjective and objective outcomes of treatment (Appendix 1). For
example, studies that only used the visual analog scale (VAS) to assess outcomes of treatment were
removed. Three studies were identified as suitable for our research.

Figure 1. PRISMA diagram of search results including inclusion and exclusion criteria.
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Results
Study #1: Chronic Plantar Fasciitis: Effect of Platelet Rich Plasma, Corticosteroid, and Placebo.
Study Objective: To compare the effectiveness of PRP and corticosteroid injections in the treatment of
chronic plantar fasciitis.
Study Design: This was a prospective randomized double-blind placebo control study of 75 patients with
clinically diagnosed chronic plantar fasciitis. Patients had no response to at least three months of
conservative therapy including physical therapy, NSAIDS, bracing, and orthotics.
Patients were randomly divided by computer-derived random charts into three groups. Group A received
2.5 to 3 milliliters (mL) of PRP, group B received 2 mL of 40 mg of methylprednisolone, and group C
received normal saline. There were 25 patients in each group.
Mean ages of patients in groups A, B, and C were 30.72, 33.92, and 35.48 years respectively with a pvalue of 0.14 among the groups. Male to female ratios for group A, B, C were 8:17, 12:13, and 11:14
respectively.
The preparation of PRP involved drawing 27 mL of blood from the cubital vein of group A and placing it
in a glass tube containing 3 mL of citrate dextrose solution to prevent clotting. The blood was centrifuged
at 32000 rpm for 12 minutes resulting in 2.5 to 3 mL of PRP. Group B and C had 5 mL of blood drawn.
The injection was given at the point of maximum tenderness with a 22-gauge needle. During the injection,
a screen was placed between the patient’s face and the injection, so they could not see the contents of the
syringe. After injection the patients were advised to not use NSAIDS for one month and to apply ice as
needed. All patients received physical therapy.
Patients were assessed before injection and during follow up at three weeks and three months by a blinded
observer. The patients were assessed using the AOFAS Ankle and Hindfoot score which is a common
scale used to measure treatment outcomes in patients with plantar fasciitis (Appendix 1). This scale
measures pain, function, and alignment for a total of 100 points. A higher score indicates greater
improvement in symptoms and function.10
Study Results: Mean AOFAS score before injection in groups A, B, and C were 51.56, 55.72, and 50.28
respectively. These scores improved to 83.92, 86.60, and 53.88 at 3 weeks follow up and 88.24, 81.32,
and 50.84 at 3 months (Table 1). Group A experienced a 63% increase at three weeks and a 71 % increase
in AOFAS score at three months compared to pretreatment. Group B experienced a 55.4% increase at
three weeks and a 46% increase at three months, when compared to pretreatment values.
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AOFAS scores in group A and B improved significantly at three weeks (P=0) and three months (P=0). In
group C, no significant difference was seen in AOFAS score at 3 weeks (P=0.06) or 3 months (P=0.39)
Comparison of groups A and B showed no significant difference in AOFAS score before injection
(P=0.20). At three weeks follow up, group B had a better outcome when compared to group A, but
difference was not significant (P=0.33). At three months group A had significantly higher AOFAS score
compared to group B (P=0.00). A p-value less than 0.05 was considered statistically significant.
The authors concluded that local injection of PRP is as effective or more effective than corticosteroid at
three-month follow up.
Table 1. AOFAS scores prior to injection, at three weeks and three months for group A, group B and
group C.
% Increase from

Prior to Injection

3 Weeks

3 Months

Group A (PRP)

51.56

83.92

88.24

71%

Group B (Corticosteroid)

55.72

86.60

81.32

46%

Group C (Saline)

50.28

53.88

50.84

0

pretreatment to 3 months

Study Critique: Limitations of this study include a small sample size of 75 participants and short length
of follow-up (three months). In addition, other limitations include clinical diagnosis of plantar fasciitis
without the utilization of plain x-ray or MRI to confirm diagnosis. While plantar fasciitis is a clinical
diagnosis these studies provide extra support and comparisons for diagnosis and research purposes as well
as confirming no other foot pathologies are present (i.e. stress fractures). Strengths included double
blinded study, utilization of computer randomized with equal subjects in each group, and a comparison
placebo group.
Study #2: Plantar Fasciitis- A Comparison of Treatment with Intralesional Steroids versus Platelet Rich
Plasma A Randomized, Blinded Study
Study Objective: Compare the use of intralesional steroids to intralesional PRP, using pain scales and
functional evaluation, in patients with plantar fasciitis who did not respond to conservative treatment.
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Study Design: This was a controlled, randomized, blinded clinical assay of 32 patients who were
diagnosed with plantar fasciitis in the outpatient clinic by the same orthopedist. X-ray and MRI were
completed to rule out stress fractures in all patients. Inclusion criteria included skeletally mature patients
with heel pain at the insertion of the plantar fascia, failure of conservative treat for three months such as
orthotics and NSAIDS and no previous infiltrations. Exclusion criteria included patients with associated
pathologies such as alterations in ipsilateral ankle and knee, osteoarthritis, rheumatoid arthritis,
ankylosing spondylitis, Reiter’s syndrome, neurological abnormalities, skin infections, or history of
infection at the application site in the previous three months (Table 2).
Patients were randomly assigned to two groups by selecting a sealed envelope. All procedures were
performed by the same researcher, who was blinded to the application via covered syringes. Further
assessments were performed by a different investigator who was also blinded to the treatment.
Patient demographics included 32 patients divided into two groups of 16 patients. Two patients in each
group (four total) were excluded for failure to follow up, resulting in a total of 28 (14 per group). Average
age of participants was 44.8 (24-61) years and 80% of participants were female.
The steroid treatment group received 8 mg of dexamethasone plus 2 mL of lidocaine. Medication was
injected in the anteromedial zone of calcaneus. The PRP treatment group had 40 mL of whole blood
drawn from basilic or antecubital vein into a vacuum sealed tube with 3.8% sodium citrate as an
anticoagulant. The blood was centrifuged for ten minutes. The upper plasma layer was removed leaving 3
mL in which the platelets were re-suspended. Prior to administration, platelets were activated by adding
0.45 mL of 10% calcium gluconate. The activated PRP was aspirated with a 5 mL syringe and injected
into the patient.
Patients were evaluated prior to treatment and at 2, 4, 12, and 16 weeks post treatment with the AOFAS
scale.
Table 2. Exclusion criteria for Acosta-Olivo et al. Study
-

Other associated pathologies (alterations in ipsilateral ankle and knee, osteoarthritis,
rheumatoid arthritis, ankylosing spondylitis, Reiter’s syndrome)

-

Neurological abnormalities

-

Skin infections

-

History of infection at the application site (within the previous three months)
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Study Results: AOFAS scores for the steroid group at pretreatment, 2, 4, 8, 12, and 16 weeks were 67.6,
82.6, 86.8, 91.4, 96.8, 97.2 respectively (Table 3). AOFAS score increased by 43.2% between
pretreatment and 16 weeks (Table 3). AOFAS scores for PRP group at pretreatment, 2, 4, 8, 12, and 16
weeks were 72.3, 80.8, 85.9, 96.1, 94.4, 96.2 respectively. P-values of the steroid group versus the PRP
group at pretreatment, 2, 4, 8, 12, 16 weeks were 0.22, 0.54, 0.76, 0.21, 0.25, 0.73 respectively (Table 3).
There was a 33% increase in AOFAS scores between pretreatment and 16 weeks. Little difference in
AOFAS scores were displayed between the study groups prior to treatment and all patients showed
improvement in symptoms over the course of the study. No significant differences were observed
between the 2 groups. A p-value of less than 0.05 was considered statistically significant.
The authors conclude that use of PRP is an effective treatment method for patients with plantar fasciitis
who have failed conservative treatment and has equal efficacy as steroids, without the associated
complications.
Table 3. Results of steroid group vs PRP group at pretreatment, 2, 4, 8, 12 and 16 weeks
Pretreatment 2 Weeks

4 Weeks

8 Weeks

12 Weeks

16 Weeks

Steroid Group 67.6

82.6

86.8

91.4

96.8

97.2

PRP Group

72.3

80.8

85.9

96.1

94.4

96.2

P-values

0.22

0.54

0.76

0.21

0.25

0.73

Study Critique
Strengths of this study include use of standardized scales and the absence of complications with either of
the two types of injections. Weakness of this study included a small sample size, short follow up period,
and inclusion of more epidemiological data. In addition, a majority (80%) of patients in this study were
female and four patients failed to follow up.
Study #3: Platelet- Rich Plasma Efficacy Versus Corticosteroid Injection Treatment for Chronic Severe
Plantar Fasciitis
Study Objective: To compare the efficacy of PRP to corticosteroid injection in the treatment of chronic
plantar fasciitis that failed traditional nonoperative management.
Study Design: This study was a single-blinded, prospective, randomized comparative study of 40 patients
who were diagnosed with chronic unilateral plantar fasciitis and failed traditional non- operative
treatments including rest, physical therapy, silicone heel lifts, CAM walker bracing, cast immobilization,
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night splinting, and non-steroidal medication. Prior to the start of the study diagnosis of plantar fasciitis
was confirmed via plain radiographs and MRI. Inclusion criteria included a four-month minimum of
standard treatment with little to no relief of symptoms. Exclusion criteria was not reported by the
researchers.
Demographics for the study included 23 females and 17 males. The male and female participants between
the PRP and corticosteroid groups had varying heights and body mass indexes (BMI). Males in the PRP
had a higher average BMI than males in the corticosteroid group. Females in the PRP group were, on
average, taller and had a lower BMI than the females in the corticosteroid group. The authors reported
that although differences were noted in in height, weight and BMI among the patient groups, they were
not statistically significant
Patients were randomized into two groups of 20 patients per group. Group 1 was treated with 40 mg of
methylprednisolone via ultrasound guidance. Group 2 was treated with autologous PRP. To prepare the
PRP 27 mL of venous blood was obtained from each participant and mixed with 3 mL of anticoagulant
citrate. The blood was centrifuged for 12 minutes. 3 mL of PRP was obtained from the “buffy coat” for
injection. For both groups, the injection site was cleansed prior to injection with 2% chlorhexidine
gluconate/70% isopropyl alcohol and a local anesthetic field block was performed using 6 mL of 0.5%
bupivacaine.
Upon completion of injections, participants were placed in a CAM walker brace for two weeks. In
addition, patients were given an exercise regimen consisting of calf/arch stretching and the Swedish heel
drop program. Participants were not to use NSAIDs in the first two weeks after their injection and were
discouraged from using them throughout the length of the entire study.

Study Results: The corticosteroid group consisted of 9 males and 11 females with an average age of 59.
The average AOFAS score of the corticosteroid group prior to treatment was 52. At 3 months this score
increased to 81, but then decreased at 6 and 12 months to 74 and 58 and then ultimately returned to near
baseline at a score of 56 at 24 months (Table 4).
The PRP group consisted of 8 males and 12 females with an average age of 51. The average AOFAS
score of the PRP group was 37 prior to beginning treatment. At 3 months this score increased to 95 and
remained elevated at 6, 12 and 24 months with scores of 94, 94 and 92 respectively (Table 4).
Results showed a clinically significant difference between AOFAS scores of the corticosteroid and PRP
groups at 3, 6, 12, and 24 months (P=.001, 95% confidence interval). The authors concluded that the use
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of local PRP injection was more successful in the long-term management of plantar fasciitis than
corticosteroid injections.

A p-value of less than 0.05 was considered statistically significant with a confidence interval of 95% for
all tests.

Table 4. Comparison of AOFAS scores of corticosteroid group vs PRP group
Prior to Treatment

3 Months

6 Months

12 Months

24 Months

Corticosteroid Group

52

81

74

58

56

PRP Group

37

95

94

94

92

Study Critique: Limitations of this study included small sample size, unclear exclusion criteria of the
study participants, and single-blinded only. Furthermore, there was a difference in volume of injection
between the 2 groups which the authors note to be of unknown significance. Strengths include
randomization, long length of follow-up, high patient retention, similar injection techniques, and the
investigation of the statistical significance of confounding variables such as differences in height and
weight.
Discussion
Plantar fasciitis is one of the most common causes of heel pain. It typically presents with
localized tenderness over the medial calcaneal tubercle and is initially treated with conservative methods
such as stretching, orthotics, and NSAIDS. For persistent chronic plantar fasciitis, injection of
corticosteroid is the preferred non-surgical treatment. Although corticosteroids are effective in reducing
pain associated with plantar fasciitis their use comes with a significant risk fascia rupture.11
In recent years, the use of PRP injections to treat chronic plantar fasciitis that has failed
traditional therapy has gained interest due to its presumed ability to reduce pain presumably without the
risk of plantar fascia rupture.8 Relatively few studies have been done to analyze the effectiveness of PRP
compared to steroids injections and those completed studies have produced mixed results. However, a
majority of these studies show promising data that PRP is as effective, if not more effective than steroids
in the treatment of plantar fasciitis.7,8,9
The results of this review revealed that PRP injections are as efficacious as steroid injections in
the treatment of plantar fasciitis that does not respond to conservative treatment, but not necessarily
superior. All three studies used a statistical significance cut off of (p = 0.05). An overview of the three
studies is provided in Table 5.
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Of the three studies, study 1 and study 3 showed that PRP was superior to corticosteroids in the
long-term treatment of plantar fasciitis (p= 0.00, 0.01 respectively). Study 2 concluded that the two
treatments had no statistically significant difference in efficacy at 16 weeks (p= 0.73). Interestingly, study
1 showed that the steroid group had higher AOFAS scores at 3 weeks, but PRP had higher scores at 3
months. Study 3 revealed a similar pattern of findings as the steroid group had improved scores at 3
months but at 24 months scores had returned to pretreatment findings. Conversely, PRP scores steadily
increased over the course of treatment and remained elevated at 24 months. These findings suggest that
PRP could be superior to steroids in providing long term relief of plantar fasciitis.
Table 5. Comparison of Mahindra et al., Acosto- Olivo et al. and Monto
Mahindra et al. (study 1)
Prospective randomized
Study Design

double- blind placebo
control study

Acosto- Olivo et al. (study 2)

Monto (study 3)
single- blinded,

controlled, randomized,

prospective,

blinded study

randomized
comparative study

Assessment Method

AOFAS

AOFAS

AOFAS

Patients, N

75

32

40

Age

~33.37

44.8

~55

Gender

44F: 31M

25.6F: 6.4M

23F: 17M

Pretreatment, 3 weeks, 3

Pretreatment, 2, 4, 8, 12, 16

Pretreatment 3, 6,

months

weeks

12, 24 months

Clinical

Clinical, MRI, X-ray

Clinical, MRI, X-ray

3 months

3 months

4 months

P= 0.00

P= 0.73

P= 0.01

AOFAS Score Timing
Diagnosis
Definition of Chronic
Plantar Fasciitis
P- Values
Study Conclusion

PRP superior to
corticosteroids

Equal efficacy

PRP superior to
corticosteroids

Of the three studies, Study 1 had the largest sample size of 75 patients. Study 2 and 3 had similar
sample sizes of 32 and 40 participants. Study 1, 2, and 3 had more women than men (Table 5). Study 2
had the largest difference in genders, with a ratio of 25.6 females to 6.4 males. Study 3 had the longest
follow of 24 months. Study 1 had the shortest follow up time of 3 months and the least frequent follow up
with two reassessments of AOFAS scores at 3 weeks and 3 months.
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All three studies examined patients with chronic plantar fasciitis. Study 3 defined patients with
chronic plantar fasciitis as those who experienced symptoms for at least four months despite conservative
treatment. Conservative treatment was defined as rest, physical therapy, silicone heel lifts, CAM walker
bracing, cast immobilization, night splinting, and NSAIDS. Plantar fasciitis diagnosis was confirmed with
X-ray and MRI. Study 2 defined chronic plantar fasciitis as failure of conservative treatment for 3
months. They defined conservative treatments as orthotics and NSAIDS. Similar to study 3, X-ray and
MRI was utilized to confirm diagnosis. Study 1 defined failure of conservative treatment as 3 months
similarly to study 2. Study 1 defined conservative treatment as physical therapy, NSAIDS, bracing and
orthotics. Unlike study 3 and study 1, imaging techniques (X-ray, MRI) were not utilized.
Adverse effects of PRP therapy, such as plantar fascia rupture, were not mentioned or reported in
all three studies. In the future, more long-term prospective studies should be done to examine the adverse
effects of PRP injections.
Strengths of this review include utilization of a standardized scale to evaluate the results from all
three studies (AOFAS scale). The use of the AOFAS scale allows for comparisons and accurate
conclusions to be drawn about the patient’s subjective and objective responses to the PRP injections,
corticosteroid injections, or placebo injections across all three studies.10 Study 1 provided the use of a
placebo group, which has not been part of the methodology of any other study. The placebo group allows
for further support of both corticosteroid and PRP as treatment for plantar fasciitis. Other strengths
included that all three studies were published within the last 4 years and the long follow up period (24
months) of study 3.
Limitations of this review include a small sample size, short length of follow up, use of different
types and amounts of steroids, method of injection, and sample selection. Small sample size and length of
follow are a major limitation of our review and show the need for larger scale studies. The three studies
use different types and amounts of steroids. In addition, injections were administered either by ultrasound
guided injections or at the point of maximal tenderness. Each study had differing exclusion and inclusion
criteria. Specifically, only study 2 excluded for other conditions that may cause pain in the area of the
plantar fascia. Lastly, the use of more female subjects than male subjects in each group is a further
limitation.
The AOFAS ankle score is a survey that includes a mixture of subjective and objective questions
and involves participation of both the patient and the provider. However, since its creation, it has raised
some concerns with regards to its validity and reliability.10 The use of this score to compare our studies
poses a limitation due to the subjective nature of the questionnaire.
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Potential bias was noted in study 3 as the author is a consultant for Exactech Inc. (Gainesville,
Fl), which is the company that develops the preparation system used in his study (Accelerate Sport
Platelet Concentration System). Study 1 and study 2 reported no conflicts of interest.

Conclusion
The use of PRP injections have shown to be as effective and, in some cases, more effective than
corticosteroid injections in the treatment of chronic plantar fasciitis. The results of this review show
exciting potential advancements in the treatment of chronic plantar fasciitis without the risk of plantar
fascia rupture as seen in corticosteroids treatment. In addition, this review reveals that the positive effects
of treatment with PRP may not wane as they do with corticosteroid injections (study 2). While PRP may
be as efficacious as corticosteroid injections there are several factors that complicate its implications as a
treatment including price of injections and lengthy time to prepare.9
Further research is necessary to understand the full spectrum of treatment implications and
complications of the use of PRP injections. Future research studies should include larger sample sizes
with longer lengths of follow-up to fully assess the utilization of PRP in plantar fasciitis treatment. In
addition, future research should control for and differentiate between conditions that could contribute to
or complicate plantar fasciitis such as obesity.
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Appendix 1. Outcomes measured using the AOFAS ankle and hindfoot scoring system.10
AOFAS Ankle and Hindfoot Scale (100 Points Total)
Pain (40 Points)
- None (40)
- Mild, Occasional (30)
- Moderate, daily (20)
- Severe, almost always present (0)
Function (50 Points)
Activity limitations, Support requirement
- No limitations, no support (10)
- No limitations of daily activities, limitation of recreational activities, no support (7)
- Limited daily and recreational activities, cane (4)
- Severe limitation of daily and recreational activities, walker, crutches, wheelchair, brace (0)
Maximum walking distance, blocks
- Greater than 6 (5)
- 4-6 (4)
- 1-3 (2)
- Less than 1 (0)
Walking surfaces
- No difficulty on any surface (5)
- Some difficulty on uneven terrain, stairs, inclines, ladders (3)
- Severe difficulty on uneven terrain, stairs, inclines, ladders (0)
Gait abnormality
- None, slight (8)
- Obvious (4)
- Marked (0)
Sagittal motion (flexion plus extension)
- Normal or mild restriction (30° or more) (8)
- Moderate restriction (15° - 29°) (4)
- Severe restriction (less than 150°) (0)
Hindfoot motion (inversion vs eversion)
- Normal or mild restriction (75%- 100% normal) (6)
- Moderate restriction (25%- 74%) (3)
- Marked restriction (less than 25% normal) (0)
Ankle- hindfoot stability (anteroposterior, varus- valgus)
- Stable (8)
- Unstable (0)
Alignment (10 Points)
- Good, plantigrade foot, midfoot well aligned (15)
- Fair, plantigrade foot, some degree of midfoot malalignment observed, no symptoms (8)
- Poor, nonplantigrade foot, severe malalignment, symptoms (0)
Total = 100
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